Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.99% | 156.12 | 0.7% | $1151.45m | |
| PFE | Pfizer Inc. | 0.50% | 34.37 | 0.9% | $1063.61m | |
| MRK | Merck & Co., Inc. | 1.34% | 73.14 | 0.7% | $859.53m | |
| BMY | Bristol-Myers Squibb Co. | 1.75% | 60.38 | 1.0% | $833.94m | |
| ABBV | AbbVie, Inc. | 0.99% | 106.70 | 1.9% | $716.41m | |
| LLY | Eli Lilly & Co. | 3.13% | 206.81 | 1.1% | $635.54m | |
| AZN | AstraZeneca Plc | 1.76% | 48.06 | 1.2% | $486.33m | |
| GSK | GlaxoSmithKline Plc | 1.84% | 34.91 | 0.2% | $272.42m | |
| NVS | Novartis AG | 0.64% | 84.03 | 0.2% | $166.37m | |
| SNY | Sanofi | 1.50% | 46.59 | 0.2% | $163.16m | |
| VTRS | Viatris, Inc. | 2.36% | 13.91 | 0.0% | $134.52m | |
| VERU | Veru, Inc. | 1.15% | 12.33 | 0.0% | $121.05m | |
| KALV | KalVista Pharmaceuticals, Inc. | -2.16% | 30.88 | 0.4% | $99.62m | |
| NVO | Novo Nordisk A/S | 0.58% | 69.62 | 0.1% | $91.37m | |
| CVAC | CureVac NV | 1.67% | 82.69 | 0.0% | $80.07m |
Company Profile
Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its lead product VP-102, is a proprietary topical therapy used in common skin indications including Molluscum contagiosum and Verruca Vulgaris. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.